Key statistics
On Wednesday, Enliven Therapeutics Inc (ELVN:NSQ) closed at 28.01, -7.31% below its 52-week high of 30.22, set on Feb 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 28.06 |
|---|---|
| High | 28.17 |
| Low | 26.43 |
| Bid | -- |
| Offer | -- |
| Previous close | 27.93 |
| Average volume | 918.99k |
|---|---|
| Shares outstanding | 59.35m |
| Free float | 54.46m |
| P/E (TTM) | -- |
| Market cap | 1.66bn USD |
| EPS (TTM) | -1.85 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
- Enliven Reports Positive Initial Phase 1b Data for ELVN-001 in CML and Outlines 2026 Clinical Milestones
- Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
- Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- Enliven Therapeutics Announces New CEO to Drive Next Phase of Development
